Committed Investment: December, 2021
Status: Active Portfolio Company
Isomark Health commercialized a breakthrough breath technology that detects breath biomarkers for infection within hours of onset. Focusing on the agricultural sector, their technology aids in timely point-of-care treatment decisions, offering an early, non-invasive, and cost-effective infection detection system.
